- • AstraZeneca
- • Swiss Rockets AG
- • Cancer Research Horizons
- • Sandoz
- • CureVac SE
- • CDR-Life AG
- • Debiopharm
- • Bristol Mayer Squibb
- • Netherlands Patent Office
- • CSL
- • Adalvo Ltd
- • Boehringer ingelheim
- • Galenicum Health
- • Immunocore
- • Novartis
- • Alkermes Pharma Ireland Limited
- • BioInvent International AB (publ)
- • Sandoz Limited
- • Leyden Labs
- • UK BioIndustry Association (BIA)
- • Germany Patent and Trademark office
- • Novartis
- • Roche
- • Straumann Group
- • Recordati
- • Debiopharm
- • Genevant Sciences GmbH
- • BAT
- • UPC
- • Leo Pharma
- • Medmix
- • European Patent Office
- • IGI Therapeutics SA
- • Recordati
- • Takeda
- • SHL Medical
- • Sygenta
- • Align Technology
- • Polpharma
- • Valneva
- • Novo Nordisk
- • BIAL
- • Lonza
- • Medmix
- • Telix Pharmaceuticals
- • CSL
- • Bristows LLP
- • Greaves Brewster LLP
- • Neuwerk Partnerschaft von Rechtsanwält:innen mbB
- • Daniel Law
- • D Young and Co LLP
- • Adams and Adams
- • Dannemann Siemsen
- • Griffith Hack
- • Davies Collison Cave
- • RNA Law
- • Rentsch Partner Ltd.
- • Elkington and Fife LLP
- • Carpmaels and Ransford LLP
- • Advokatbyrån Gulliksson AB
- • Hogan Lovells
- • E. Blum and Co. AG
- • Freshfields LLP
- • HOYNG ROKH MONEGIER
- • Lenz and Staehelin
- • Hoffmann Eitle
- • BSKB
- • ATExIPS GmbH and President of EPI
.png)
Where Life Sciences IP Strategy Comes Full Circle
22–23 September 2026 | Marriott Basel, Switzerland
Two Days | 180 Attendees
An agenda shaped by the needs of senior pharma and biotech executives
.png)
Balanced 1:1 ratio of in-house counsel and private practice professionals
Bringing the entire life sciences IP ecosystem together under one roof this September.
Where Life Sciences IP Strategy Comes Full Circle
Life sciences IP is entering a new era, where patent prosecution, litigation strategy, regulatory frameworks, and commercial objectives must operate as one. As the Unified Patent Court (UPC) reshapes enforcement across Europe, AI transforms prosecution workflows, and the EU Pharma Package redefines exclusivity, organisations are under increasing pressure to build resilient, commercially aligned IP strategies.
The opportunities for innovation and growth have never been greater, but success depends on strategic coordination, operational efficiency, and the ability to adapt quickly to a shifting legal and regulatory landscape. From cross-border litigation and SPC reform to biologics disputes and AI-driven drug discovery, the stakes are higher than ever for life sciences innovators.
Join Europe's leading IP counsel, patent attorneys, litigators, regulators, pharmaceutical and biotech leaders at Life Sciences Patent Network Europe 2026, taking place 22–23 September in Basel, Switzerland — one of Europe's leading pharmaceutical and biotech hubs.
Over two days, senior decision-makers from organisations including Novartis, Novo Nordisk, BAT, Roche, Leo Pharma, Recordati, SHL Medical, Syngenta, Lonza, and the Unified Patent Court (UPC) will come together to explore:
What You'll Explore Over Two Days
How to strengthen patent portfolios from filing through enforcement.
Navigating the evolving UPC and EPO opposition landscape.
The impact of the EU Pharma Package on exclusivity and lifecycle strategy.
AI in patent prosecution and IP workflow optimization.
Cross-border litigation strategy and enforcement trends.
Clinical trial transparency and its implications for patent timing.
Building litigation-ready in-house IP functions aligned with business objectives.
📍 Basel, Switzerland | 22–23 September 2026
Join leaders from Novartis, Novo Nordisk, Roche, Leo Pharma, Syngenta, Lonza, and the Unified Patent Court (UPC).
Introducing the 2026 LSPN Europe Speaking Faculty
Who Attends LSPN Europe?
Make meaningful connections with industry decision-makers and global legal practitioners.
Attending Companies
Pharma and
Biotech
Pharma and
Biotech
Law Firms and
Solution Services
2026 Confirmed Partners
Coffee Sponsor
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Why This Is The Event For You
End-to-End IP Strategy
Comprehensive coverage spanning across the full patent lifecycle, from initial filing through to enforcement.
Case-Led Practical Learning
Grounded in real-world disputes, landmark court decisions, and actionable legal precedents.
Senior-Level Networking
Connect directly with Chief IP Counsel, General Counsel, and Heads of IP Strategy and Litigation.
Interactive Strategy Circles
Engaging roundtables delivering valuable peer-to-peer insights and key actionable takeaways.
Direct Access to Key Authority
Engage with UPC judges, patent office representatives, and leading practitioners shaping life sciences IP.
Balanced 1:1 Audience Ratio
Maintaining a balanced ratio of in-house counsel to private practice professionals to encourage meaningful networking and knowledge exchange.
Speaker Spotlight Interviews
Exclusive Insights from the Leaders Shaping the Future of Life Sciences IP
Ahead of LSPN Europe 2026, we've sat down with leading in-house counsel and private practice experts to discuss the challenges that are redefining patent strategy across Europe and beyond.
LSPN Europe Highlights
Get a glimpse of the networking, keynote presentations, and insights from our previous event.
Register for LSPN Europe 2026
Join Europe's leading life sciences IP professionals this September in Basel. Register today.
Ayo Fagbohun
Senior Business Development Manager
Newton Media
Rochelle Clarke
Client Engagement Manager
Newton Media
LSPN Europe 2026 is produced by Newton Media
Contact Us
Newton Media
Kingfisher House
21-23 Elmfield Road
Bromley
BR1 1LT
United Kingdom
Email: info@newtonmedia.co.uk
